Thus far, TRIP8b has not been directly implicated in depression in humans, however, as noted in a prior review, studies primarily focus on genes associated with increases in depression so that a lack of direct evidence for anti-depressant activity of TRIP8b is not surprising (Han et al., 2020). This evidence concerns the gene PEX5L and major depressive disorder.